111 related articles for article (PubMed ID: 15484695)
1. Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy.
Nafe R; Herminghaus S; Pilatus U; Hattingen E; Marquardt G; Schlote W; Lanfermann H; Zanella F
Neuropathology; 2004 Sep; 24(3):172-82. PubMed ID: 15484695
[TBL] [Abstract][Full Text] [Related]
2. Correlation between preoperative magnetic resonance spectroscopic data on high grade gliomas and morphology of Ki-67-positive tumor cell nuclei.
Nafe R; Herminghaus S; Raab P; Wagner S; Pilatus U; Schlote W; Zanella F; Lanfermann H
Anal Quant Cytol Histol; 2003 Jun; 25(3):131-8. PubMed ID: 12882084
[TBL] [Abstract][Full Text] [Related]
3. Correlation between amplification of the gene for the epidermal growth factor receptor (EGFR), data from preoperative proton-MR-spectroscopy (1HMRS) and histomorphometric data of glioblastomas.
Nafe R; Glienke W; Hattingen E; Schlote W; Lanfermann H; Zanella F
Anal Quant Cytol Histol; 2007 Aug; 29(4):199-207. PubMed ID: 17879627
[TBL] [Abstract][Full Text] [Related]
4. Preoperative proton-MR spectroscopy of gliomas--correlation with quantitative nuclear morphology in surgical specimen.
Nafe R; Herminghaus S; Raab P; Wagner S; Pilatus U; Schneider B; Schlote W; Zanella F; Lanfermann H
J Neurooncol; 2003 Jul; 63(3):233-45. PubMed ID: 12892229
[TBL] [Abstract][Full Text] [Related]
5. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas.
Nafe R; Franz K; Schlote W; Schneider B
Clin Cancer Res; 2005 Mar; 11(6):2141-8. PubMed ID: 15788659
[TBL] [Abstract][Full Text] [Related]
6. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time.
Nafe R; Franz K; Schlote W; Schneider B
Oncol Rep; 2006 Sep; 16(3):555-62. PubMed ID: 16865255
[TBL] [Abstract][Full Text] [Related]
7. EGFR gene amplification in glioblastomas. Is there a relationship with morphology of tumor cell nuclei and proliferative activity?
Nafe R; Glienke W; Schlote W; Schneider B
Anal Quant Cytol Histol; 2001 Apr; 23(2):135-43. PubMed ID: 11332080
[TBL] [Abstract][Full Text] [Related]
8. Regional heterogeneity of EGFR gene amplification and nuclear morphology in glioblastomas. An investigation using laser microdissection and pressure catapulting.
Nafe R; Glienke W; Burgemeister R; Gangnus R; Haar B; Pries A; Schlote W
Anal Quant Cytol Histol; 2004 Apr; 26(2):65-76. PubMed ID: 15131893
[TBL] [Abstract][Full Text] [Related]
9. Quantitative investigation of nuclear morphology in glioblastomas and its relation to survival time.
Nafe R; Franz K; Schlote W; Schneider B
Clin Neuropathol; 2003; 22(3):129-36. PubMed ID: 12809355
[TBL] [Abstract][Full Text] [Related]
10. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
11. Discrimination of brain abscess and cystic tumor by in vivo proton magnetic resonance spectroscopy.
Kadota O; Kohno K; Ohue S; Kumon Y; Sakaki S; Kikuchi K; Miki H
Neurol Med Chir (Tokyo); 2001 Mar; 41(3):121-6. PubMed ID: 11372554
[TBL] [Abstract][Full Text] [Related]
12. Topometric analysis of diffuse astrocytomas.
Nafe R; Schlote W
Anal Quant Cytol Histol; 2003 Feb; 25(1):12-8. PubMed ID: 12630077
[TBL] [Abstract][Full Text] [Related]
13. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
Fan G; Sun B; Wu Z; Guo Q; Guo Y
Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
[TBL] [Abstract][Full Text] [Related]
14. Histomorphometry of tumour cell nuclei in astrocytomas using shape analysis, densitometry and topometric analysis.
Nafe R; Schlote W; Schneider B
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):34-44. PubMed ID: 15634229
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of dividing cells in live rodent brain by proton magnetic resonance spectroscopy (1HMRS) and LCModel analysis.
Park JH; Lee H; Makaryus R; Yu M; Smith SD; Sayed K; Feng T; Holland E; Van der Linden A; Bolwig TG; Enikolopov G; Benveniste H
PLoS One; 2014; 9(5):e94755. PubMed ID: 24819091
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
Negendank WG; Sauter R; Brown TR; Evelhoch JL; Falini A; Gotsis ED; Heerschap A; Kamada K; Lee BC; Mengeot MM; Moser E; Padavic-Shaller KA; Sanders JA; Spraggins TA; Stillman AE; Terwey B; Vogl TJ; Wicklow K; Zimmerman RA
J Neurosurg; 1996 Mar; 84(3):449-58. PubMed ID: 8609557
[TBL] [Abstract][Full Text] [Related]
17. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Kinoshita Y; Yokota A
NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.
Chawla S; Zhang Y; Wang S; Chaudhary S; Chou C; O'Rourke DM; Vossough A; Melhem ER; Poptani H
J Comput Assist Tomogr; 2010; 34(6):836-41. PubMed ID: 21084897
[TBL] [Abstract][Full Text] [Related]
19. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement.
Kimura T; Sako K; Gotoh T; Tanaka K; Tanaka T
NMR Biomed; 2001 Oct; 14(6):339-49. PubMed ID: 11599032
[TBL] [Abstract][Full Text] [Related]
20. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma.
Gupta RK; Cloughesy TF; Sinha U; Garakian J; Lazareff J; Rubino G; Rubino L; Becker DP; Vinters HV; Alger JR
J Neurooncol; 2000 Dec; 50(3):215-26. PubMed ID: 11263501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
